Ticker LaunchIPO · GLUE
Monte Rosa Therapeutics, Inc.
Formerly Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc. (GLUE) priced its initial public offering on Jun 25, 2021 at $19.00 per share, within its $17.00–$19.00 range, raising $222.3M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $845.3M. J.P. Morgan was lead-left underwriter. Latham & Watkins advised the underwriters.
- Status
- IPO
- Ticker
- GLUE
- Exchange
- Nasdaq Global Select
- Priced
- Jun 25, 2021
- IPO price
- $19.00
- Price range
- $17.00–$19.00
- Raised
- $222.3M
- Market cap at IPO price
- $845.3M
- First filed
- Jun 4, 2021
- Underwriters
- J.P. Morgan
- Underwriters' counsel
- Latham & Watkins
- Sector
- Biotech & pharma
- Country / state
- MA
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Jun 4, 2021
- Latest amendment Jun 21, 2021
- Final prospectus (424B4) Jun 25, 2021
- All filings on EDGAR CIK 1826457
Other Biotech & pharma IPOs in 2021
- Acurx Pharmaceuticals, Inc.ACXP · Jun 28, 2021
- GH Research PLCGHRS · Jun 28, 2021
- Bon Natural Life LtdBON · Jun 25, 2021 · $11M
- Elevation Oncology, Inc.ELEV · Jun 25, 2021
- Alpha Teknova, Inc.TKNO · Jun 25, 2021 · $96M
- Miromatrix Medical Inc.MIRO · Jun 24, 2021 · $43.2M